ABINGTON AEROMEDICAL LTD

Company Registration Number:
10511767 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

ABINGTON AEROMEDICAL LTD

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

ABINGTON AEROMEDICAL LTD

Balance sheet

As at 31 December 2024


Notes
2024
2023


£
£
Fixed assets
Tangible assets: 3 11,126 8,725
Investments: 4 836,587 836,587
Total fixed assets: 847,713 845,312
Current assets
Debtors:   551,570 513,429
Cash at bank and in hand: 21,320 215,181
Total current assets: 572,890 728,610
Creditors: amounts falling due within one year:   (680,900) (870,806)
Net current assets (liabilities): (108,010) (142,196)
Total assets less current liabilities: 739,703 703,116
Provision for liabilities: (14,996) (26,773)
Total net assets (liabilities): 724,707 676,343
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 724,706 676,342
Shareholders funds: 724,707 676,343

The notes form part of these financial statements

ABINGTON AEROMEDICAL LTD

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 September 2025
and signed on behalf of the board by:

Name: Michael Fonso
Status: Director

The notes form part of these financial statements

ABINGTON AEROMEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ABINGTON AEROMEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 2 2

ABINGTON AEROMEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible Assets

Total
Cost £
At 01 January 2024 33,377
Additions 4,794
At 31 December 2024 38,171
Depreciation
At 01 January 2024 24,652
Charge for year 2,393
At 31 December 2024 27,045
Net book value
At 31 December 2024 11,126
At 31 December 2023 8,725

ABINGTON AEROMEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Fixed investments

The company has invested in property sector overseas.